Sage Therapeutics, Inc. (SAGE) stock slides, “Buy” rating reiterated by J P Morgan Chase & Co Analysts

Sage Therapeutics, Inc. (NASDAQ: SAGE) shares fell in early trading today on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile in early trading, the Dow Jones Industrial Average DJIA, +0.31% rose 24 points, or 0.1%, to 19,883, while the S&P 500 index ESH7, +0.13% dipped less than 1 point to 2,268. The Nasdaq Composite COMP, +0.02% which reached its fourth-straight record close on Tuesday, rose 1 point to 5,553.

J P Morgan Chase & Co analysts reiterated its Buy rating on Sage Therapeutics, Inc. (NASDAQ: SAGE) in a note to investors, making it one of the more closely watched stocks on Wall Street. With a rating of Buy on the stock, the company has a 52-week high of $56.45. The one-year price target of $75.09 is higher than the opening price of $54.00, resulting a number of other analysts to comment on the stock recently. Typically, after analysts give a “reiterated rating” report on a stock, they will subsequently issue other updates, such as a price target change.

Shares of Sage Therapeutics, Inc. (NASDAQ: SAGE) opened at $54.00 yesterday and traded in a range between, $53.73 and $54.20, and last traded at $53.77, a dip of $0.08 compared to the previous closing price.

Sage Therapeutics, Inc. (NASDAQ: SAGE) now has a market cap of 2.00B.

Sage Therapeutics, Inc. (NASDAQ: SAGE) Average Daily Trading Volume

The stock’s average daily volume is 508,552 shares out of a total float 32,759,000 and some 63,945 shares traded hands yesterday, 108 percent lower than the norm. lower than normal. Look for trading volume to pick up in the coming days as investors often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for short periods will not mean much will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to make sure you are buying the right stocks.

Sage Therapeutics, Inc. (NASDAQ: SAGE) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.

With that in mind, Sage Therapeutics, Inc. (NASDAQ: SAGE) now has a 50-day MA of $50.09 and 200-day MA of $43.28. It has traded in a 52-week range between $26.28 – 56.45 and today’s last price is 4.75%% lower than the 52 week high of $56.45.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors identify companies that have been successful at growing their earnings at least 25% or more for a 3 year period.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply